Congresses Don’t Change Clinical Practice

Clinical practice rarely changes inside a congress hall. It changes weeks later, when the industry is no longer in the room.

More than 60 years ago, through his Diffusion of Innovations theory, Everett Rogers showed that new ideas spread through social reinforcement as individuals observe, validate and gain confidence from peers over time.

Medicine behaves exactly the same way.

Thanks for reading ArtiaCo.’s Substack! Subscribe for free to receive new posts and support my work.Subscribe

Congresses create awareness… adoption happens later

Clinicians rarely change practice because of a single interaction or presentation. More often, decisions are made after ideas have been reinforced through peer discussion, contextualised in real-world settings, and tested against the realities of everyday care.

That is why most congresses create awareness far more effectively than they create adoption.

Between us, the ArtiaCo. team has spent more than 75 years working across ophthalmology, industry engagement and medical communications, and we have repeatedly seen the same pattern emerge: the congress or symposium creates awareness, discussion and initial interest, but the real adoption decision happens later, once clinicians return to everyday practice.

A clinician attending a major congress today moves continuously between scientific sessions, satellite symposia, poster halls, industry meetings, peer conversations, networking dinners and informal discussions squeezed between coffees and cases.

Over the course of just a few days, they absorb hundreds of competing scientific and commercial signals simultaneously.

Very little is remembered in isolation.

And yet many engagement strategies still operate as though a single educational interaction should directly change behaviour.

In reality, most clinicians leave a congress remembering surprisingly little. Usually just a handful of things:

Something genuinely new
Something strongly evidence-based
Something peers continued discussing afterwards
Something that felt directly relevant to day-to-day clinical practice

Critically, they remember things that feel implementable.

That point is often underestimated by industry.

Clinicians do not adopt innovation simply because it is scientifically interesting. They adopt when evidence, workflow and confidence begin to align.

The questions that really matter are often highly practical:

Can I realistically implement this?
Will this work in my setting?
Will it improve outcomes without disrupting workflow?
Will trusted colleagues actually use it?

Those questions are rarely answered during the symposium itself. They are answered afterwards, usually through repeated peer validation over time.

This also helps explain why cognitive overload matters at congresses

A clinician may attend multiple satellite symposia, scientific sessions and industry events within a single day while simultaneously navigating networking conversations and peer discussions.

Behavioural research consistently shows that when individuals are exposed to large volumes of competing information, retention narrows dramatically towards what feels most novel, relevant, emotionally resonant or practically useful.

This aligns closely with the principles behind Hermann Ebbinghaus’ forgetting curve, which demonstrates that information rapidly decays from memory unless it is reinforced over time.

In healthcare, that usually means clinicians remember things that appear both evidence-based and realistically applicable to patient care and day-to-day practice.

Research examining physician professional networks, implementation science and diffusion theory has consistently shown that peer relationships strongly influence adoption behaviour, uptake and clinical decision-making.

This has been extensively explored within healthcare implementation research, including the work of Trisha Greenhalgh and colleagues on how innovation spreads through healthcare systems.

This helps explain a tension many healthcare companies quietly recognise internally

The educational event was successful…

The faculty were strong…

Feedback scores were excellent…

The room was full…

…And yet six months later, practice has barely moved.

Not because the science failed.

But because the momentum faded once clinicians returned to the realities of everyday practice.

At ArtiaCo., this is the area we believe remains structurally underestimated across much of healthcare engagement strategy.

The critical question is no longer simply: “How do we deliver educational engagement?”
It is: “What survives afterwards?”

Because this is where adoption is actually shaped.

Not during the presentation itself, but later. In peer-to-peer discussion. In local validation. In trying something in practice and hearing whether respected colleagues reached the same conclusion.

In our experience, the most commercially important congress conversations are often not the formal ones.

They happen afterwards:

The quick message between colleagues after clinic.
The follow-up discussion after trying something new.
The conversation over coffee a few weeks later.
The simple question between peers: “Are you actually using it?”

That moment still carries extraordinary weight.

Probably more than most engagement dashboards are designed to measure.

Most engagement strategies are still optimized for event performance. Very few are designed for post-event influence.

The organisations that understand this distinction will outperform those that do not.

Because in the end, congresses rarely change clinical practice on their own.

Conversations between trusted people do.

Congresses Don’t Change Clinical Practice

Clinical practice rarely changes inside a congress hall. It changes weeks later, when the industry is no longer in the room.

Congresses create awareness… adoption happens later

This also helps explain why cognitive overload matters at congresses

This helps explain a tension many healthcare companies quietly recognise internally

Further Reading

Let’s Work Together

NAVIGATION